Your browser doesn't support javascript.
loading
Contribution of TEX15 genetic variants to the risk of developing severe non-obstructive oligozoospermia.
Guzmán-Jiménez, Andrea; González-Muñoz, Sara; Cerván-Martín, Miriam; Rivera-Egea, Rocío; Garrido, Nicolás; Luján, Saturnino; Santos-Ribeiro, Samuel; Castilla, José A; Gonzalvo, M Carmen; Clavero, Ana; Vicente, F Javier; Maldonado, Vicente; Villegas-Salmerón, Javier; Burgos, Miguel; Jiménez, Rafael; Pinto, Maria Graça; Pereira, Isabel; Nunes, Joaquim; Sánchez-Curbelo, Josvany; López-Rodrigo, Olga; Pereira-Caetano, Iris; Marques, Patricia Isabel; Carvalho, Filipa; Barros, Alberto; Bassas, Lluís; Seixas, Susana; Gonçalves, João; Lopes, Alexandra M; Larriba, Sara; Palomino-Morales, Rogelio J; Carmona, F David; Bossini-Castillo, Lara.
Afiliação
  • Guzmán-Jiménez A; Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain.
  • González-Muñoz S; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • Cerván-Martín M; Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain.
  • Rivera-Egea R; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • Garrido N; Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain.
  • Luján S; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • Santos-Ribeiro S; Andrology Laboratory and Sperm Bank, IVIRMA Valencia, Valencia, Spain.
  • Castilla JA; IVI Foundation, Health Research Institute La Fe, Valencia, Spain.
  • Gonzalvo MC; IVI Foundation, Health Research Institute La Fe, Valencia, Spain.
  • Clavero A; Servicio de Urología. Hospital Universitari i Politecnic La Fe e Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
  • Vicente FJ; Servicio de Urología. Hospital Universitari i Politecnic La Fe e Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
  • Maldonado V; IVI-RMA Lisbon, Lisbon, Portugal.
  • Villegas-Salmerón J; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
  • Burgos M; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • Jiménez R; Unidad de Reproducción, UGC Obstetricia y Ginecología, HU Virgen de Las Nieves, Granada, Spain.
  • Pinto MG; CEIFER Biobanco-GAMETIA, Granada, Spain.
  • Pereira I; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • Nunes J; Unidad de Reproducción, UGC Obstetricia y Ginecología, HU Virgen de Las Nieves, Granada, Spain.
  • Sánchez-Curbelo J; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • López-Rodrigo O; Unidad de Reproducción, UGC Obstetricia y Ginecología, HU Virgen de Las Nieves, Granada, Spain.
  • Pereira-Caetano I; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • Marques PI; UGC de Urología, HU Virgen de las Nieves, Granada, Spain.
  • Carvalho F; UGC de Obstetricia y Ginecología, Complejo Hospitalario de Jaén, Jaén, Spain.
  • Barros A; Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain.
  • Bassas L; Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain.
  • Seixas S; Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain.
  • Gonçalves J; Centro de Medicina Reprodutiva, Maternidade Alfredo da Costa, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal.
  • Lopes AM; Departamento de Obstetrícia, Ginecologia e Medicina da Reprodução, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisboa, Portugal.
  • Larriba S; Departamento de Obstetrícia, Ginecologia e Medicina da Reprodução, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisboa, Portugal.
  • Palomino-Morales RJ; Laboratory of Seminology and Embryology, Andrology Service-Fundació Puigvert, Barcelona, Spain.
  • Carmona FD; Laboratory of Seminology and Embryology, Andrology Service-Fundació Puigvert, Barcelona, Spain.
  • Bossini-Castillo L; Departamento de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
Front Cell Dev Biol ; 10: 1089782, 2022.
Article em En | MEDLINE | ID: mdl-36589743
ABSTRACT

Background:

Severe spermatogenic failure (SPGF) represents one of the most relevant causes of male infertility. This pathological condition can lead to extreme abnormalities in the seminal sperm count, such as severe oligozoospermia (SO) or non-obstructive azoospermia (NOA). Most cases of SPGF have an unknown aetiology, and it is known that this idiopathic form of male infertility represents a complex condition. In this study, we aimed to evaluate whether common genetic variation in TEX15, which encodes a key player in spermatogenesis, is involved in the susceptibility to idiopathic SPGF. Materials and

Methods:

We designed a genetic association study comprising a total of 727 SPGF cases (including 527 NOA and 200 SO) and 1,058 unaffected men from the Iberian Peninsula. Following a tagging strategy, three tag single-nucleotide polymorphisms (SNPs) of TEX15 (rs1362912, rs323342, and rs323346) were selected for genotyping using TaqMan probes. Case-control association tests were then performed by logistic regression models. In silico analyses were also carried out to shed light into the putative functional implications of the studied variants.

Results:

A significant increase in TEX15-rs1362912 minor allele frequency (MAF) was observed in the group of SO patients (MAF = 0.0842) compared to either the control cohort (MAF = 0.0468, OR = 1.90, p = 7.47E-03) or the NOA group (MAF = 0.0472, OR = 1.83, p = 1.23E-02). The genotype distribution of the SO population was also different from those of both control (p = 1.14E-02) and NOA groups (p = 4.33-02). The analysis of functional annotations of the human genome suggested that the effect of the SO-associated TEX15 variants is likely exerted by alteration of the binding affinity of crucial transcription factors for spermatogenesis.

Conclusion:

Our results suggest that common variation in TEX15 is involved in the genetic predisposition to SO, thus supporting the notion of idiopathic SPGF as a complex trait.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article